Talus Bio Analysis: $20M Raised
What is Talus Bio?
Proprietary platform for measuring gene regulators
Location
Seattle, United States
Employees
11-50
Founded
2020
Product Features & Capabilities
- AI-designed chemical libraries for modulating transcription factors
- High-throughput cell-based assays generating millions of compound-target interactions
- Functional proteomics quantifying regulome targets in live cells
- Proprietary MARMOT platform for gene regulation insights
- Data-driven AI models for predicting drug interactions.
Use Cases
Identify novel drug targets in oncology and rare diseases; Develop first-in-class therapeutics targeting transcription factors; Accelerate preclinical development through toxicity prediction; Collaborate on drug discovery with innovative biotech teams; Explore gene regulation mechanisms in live cell contexts.
Other Considerations
Raised $11.2M in additional funding in 2024; Collaborates with teams pushing the boundaries of biology; Focuses on previously undruggable targets in various disease areas.
